What are the possible causes of a non-painful skull mass in an elderly female, aside from malignancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Non-Malignant Causes of Non-Painful Skull Mass in Elderly Females

The most common non-malignant causes of a skull mass in an elderly female are meningioma (representing >30% of CNS tumors), followed by intraosseous meningioma, epidermoid cysts, and rarely benign smooth muscle tumors like leiomyomas or angioleiomyomas. 1, 2

Primary Benign Differential Diagnoses

Meningiomas (Most Common)

  • Meningiomas account for more than 30% of all CNS tumors and are the most frequent benign skull lesion, with a female-to-male ratio of 2-3:1 and median diagnosis age of 65 years. 1
  • These tumors develop from meningothelial cells and commonly occur at parasagittal/falcine, convexity, sphenoid ridge, suprasellar, and skull base locations. 1
  • Grade I (benign) meningiomas represent the vast majority of cases with >80% ten-year survival, though their location can still cause significant morbidity. 1
  • On imaging, meningiomas typically appear isointense on T1 and T2 MRI with homogeneous enhancement and may show a characteristic dural tail sign. 2

Intraosseous Meningioma

  • Intraosseous calvarial meningiomas are rare variants confined to the skull bone itself, typically exhibiting osteoblastic activity but occasionally presenting as purely lytic lesions. 3
  • These can radiologically mimic malignant processes like osteosarcoma, making biopsy essential for diagnosis. 4
  • The frontoparietal and orbital regions are most commonly affected, with average diagnosis age around 50 years. 4
  • Complete surgical excision offers excellent prognosis without recurrence. 3

Leiomyomas and Angioleiomyomas

  • Skull base leiomyomas (LMs) and angioleiomyomas (ALMs) are extremely rare benign smooth muscle tumors that are usually painless and occur more commonly in females. 2
  • ALMs represent <1% of head and neck tumors, with only 39 total intracranial cases reported in the literature (19 in skull base). 2
  • These lesions can be large (up to 7.7 cm) and locally destructive but are benign with excellent prognosis after resection. 2
  • Malignancy is extremely rare when these pathologic entities are diagnosed, and they show universally low mitotic activity with no reported recurrences even after subtotal resection. 2
  • On imaging, ALMs appear hypointense/isointense on T1, isointense to hyperintense on T2, and hyperdense on CT with variable contrast enhancement. 2

Other Benign Considerations

  • Epidermoid cysts, lipomas, and arachnoid cysts represent less frequent benign skull base lesions. 2
  • Fibrous dysplasia, Paget's disease, and hemangiomas should be considered based on imaging characteristics. 5
  • Eosinophilic granuloma presents as an osteolytic lesion with characteristic bevelled edges. 5

Critical Diagnostic Pitfalls

Radiological Mimicry of Malignancy

  • Benign lesions can demonstrate radiological features suggesting malignancy, making tissue diagnosis essential before definitive treatment. 4
  • Intraosseous meningiomas may show lytic and sclerotic regions with irregular cortex that mimics osteosarcoma on CT. 4
  • ALMs may show a dural tail sign, prompting misdiagnosis as meningioma, and their vascular nature can complicate surgical resection. 2

Age-Related Considerations

  • While meningiomas have a median diagnosis age of 65 years, intraosseous variants average 50.5 years, and skull base ALMs typically occur between ages 40-60. 1, 4, 2
  • In elderly patients with small asymptomatic tumors, observation with serial imaging is appropriate, with treatment initiated only upon progression. 6

Imaging Approach

MRI as Primary Modality

  • MRI with and without IV contrast is the critical imaging modality for surgical and radiation treatment planning due to excellent soft tissue contrast and high spatial resolution. 2
  • Standardized protocols should include 3D T1 pre- and post-contrast, T2 FLAIR, diffusion-weighted imaging, and susceptibility-weighted imaging. 2

CT for Surgical Planning

  • CT without contrast provides essential information about osseous involvement, erosions, and hyperostosis that guides surgical approach. 2
  • Presence of osseous erosions is uncommon in meningiomas and should raise consideration of alternative diagnoses. 2

Distinguishing Features

  • Schwannomas show Antoni A/B patterns and S-100 positivity, appearing isointense/hypointense on T1 with intense gadolinium enhancement. 2
  • Meningiomas demonstrate homogeneous enhancement with positive staining for somatostatin receptor 2A and epithelial membrane antigen. 2

References

Research

Meningioma and Other Meningeal Tumors.

Advances in experimental medicine and biology, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Radiological review of skull lesions.

Insights into imaging, 2018

Research

Management of benign skull base meningiomas: a review.

Skull base : official journal of North American Skull Base Society ... [et al.], 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.